{"input_url":"https://pharmaphorum.com/news/re-rostered-fda-committee-backs-peptide-compounding","gnews_decode":"https://pharmaphorum.com/news/re-rostered-fda-committee-backs-peptide-compounding","http_status":200,"final_url":"https://pharmaphorum.com/news/re-rostered-fda-committee-backs-peptide-compounding","html_length":93344,"trafilatura_result":"ok","text_length":2995,"text_preview":"Re-rostered FDA committee backs peptide compounding\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tAgainst the advice of FDA staff scientists, an advisory committee has narrowly voted in support of looser restrictions on peptide therapies that are being championed by HHS Secretary Robert F Kennedy Jr.\nOn the first ","verdict":"OK"}